These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16768355)

  • 1. [Use of the recombinant activated factor VII in general surgery practice].
    Dement'eva II; Gladysheva VG; Charnaia MA; Morozov IuA
    Vestn Khir Im I I Grek; 2005; 164(5):103-5. PubMed ID: 16768355
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
    Despotis G; Avidan M; Lublin DM
    Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
    [No Abstract]   [Full Text] [Related]  

  • 3. [New possibilities in the postoperative measures to prevent bleeding in cardiac surgery. Will the recombinant activated factor VII improve surgical results?].
    Skalski JH; Czapla J; Nadziakiewicz P; Kaczmarski J; Zembala M
    Przegl Lek; 2002; 59(11):941-5. PubMed ID: 12715727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recombinant activated factor VII in uncontrolled hemorrhage].
    Colomina MJ; Altisent C; Guerrero E; Godet C
    Med Clin (Barc); 2005 Feb; 124(4):156. PubMed ID: 15713248
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
    Kogan A; Berman M; Stein M; Vidne BA; Raanani E
    J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activated recombinant factor VII for bleeding after a kidney transplant].
    Vidal MA; Sebastianes C; Eizaga R; Martínez E; Torres LM
    Rev Esp Anestesiol Reanim; 2005 Dec; 52(10):638-9. PubMed ID: 16435622
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery.
    Leibovitch L; Kenet G; Mazor K; Matok I; Vardi A; Barzilay Z; Paret G
    Pediatr Crit Care Med; 2003 Oct; 4(4):444-6. PubMed ID: 14525639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
    Yan Q; Chang AC
    Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
    [No Abstract]   [Full Text] [Related]  

  • 10. Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa.
    Girisch M; Rauch R; Carbon R; Habash T; Hofbeck M
    Eur J Pediatr; 2004 Feb; 163(2):118-9. PubMed ID: 14716558
    [No Abstract]   [Full Text] [Related]  

  • 11. NovoSeven for non-hemophilia hemostasis.
    Med Lett Drugs Ther; 2004 Apr; 46(1181):33-4. PubMed ID: 15114252
    [No Abstract]   [Full Text] [Related]  

  • 12. Administration of recombinant activated factor VII in major thoracic operations.
    Alavi AA; Jalali SM; Rasouli MR; Eghtesadi-Araghi P
    Arch Surg; 2008 Oct; 143(10):1021; author reply 1021. PubMed ID: 18936387
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
    Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
    J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
    Tofil NM; Winkler MK; Watts RG; Noonan J
    Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB
    Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant activated factor VII: a new weapon in the fight against hemorrhage.
    Branch DW; Rodgers GM
    Obstet Gynecol; 2003 Jun; 101(6):1155-6. PubMed ID: 12798515
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant activated factor VII and perioperative blood loss.
    Volk T; von Heymann C; Kox WJ
    Lancet; 2003 May; 361(9370):1745; author reply 1745-6. PubMed ID: 12767765
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant activated factor VII and perioperative blood loss.
    Williams D; McCarthy R
    Lancet; 2003 May; 361(9370):1745; author reply 1745-6. PubMed ID: 12767766
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC
    Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.